查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604630

虫媒病毒检测市场：按类型、组成部分、适应症和最终用户划分 - 2025-2030 年全球预测

Arbovirus Testing Market by Type (Enzyme-linked Immunosorbent Assays (ELISAs), RT-PCR Assays), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年虫媒病毒检测市场价值为12.4亿美元，预计到2024年将达到13.1亿美元，复合年增长率为5.81%，到2030年将达到18.5亿美元。

虫媒病毒检测是指用于检测虫媒病毒是否存在的诊断程序，虫媒病毒是透过蚊子和蜱虫等节肢动物感染人类和动物的病毒。兹卡、登革热和西尼罗河病毒等虫媒病毒感染疾病的增加增加了虫媒病毒检测的需求，主要是为了保护公众健康。此测试对于临床和媒介监测目的至关重要，并可应用于医院、诊断实验室、研究机构和现场监测单位。市场成长的推动因素包括对媒介感染疾病认识的提高、政府加大疫情控制力度以及包括 PCR 和血清学技术在内的诊断技术的进步。对快速、准确的就地检验解决方案的需求迅速增长，正在创造新的商机，尤其是在流行地区。然而，有几个因素阻碍了市场的扩张，包括先进检测设备的高价格、农村和资源匮乏环境中的物流挑战以及缺乏操作先进诊断工具的熟练人员。创新的关键领域包括开发低成本携带式诊断试剂套件，提高测试的特异性和敏感性，以及整合人工智慧来预测疫情。此外，透过将研究重点放在了解虫媒病毒突变模式和血清学检测中的交叉反应性上，可以促进进展。公司应考虑与政府和非政府组织合作，提高采用率并进行教育宣传活动，并强调早期诊断的重要性。虫媒病毒检测市场正在成长，但本质上是动态的，受到季节性趋势、区域疾病爆发和卫生政策变化的影响。因此，该行业的公司需要保持敏捷性，优先考虑研发投资，利用资料分析来了解新兴趋势，并客製化产品以满足不同的区域需求。

主要市场统计
基准年[2023] 12.4亿美元
预计年份 [2024] 13.1亿美元
预测年份 [2030] 18.5亿美元
复合年增长率（%） 5.81%

市场动态：揭示快速发展的虫媒病毒检测市场的关键市场洞察

虫媒病毒检测市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 虫媒病毒在人群中的盛行率上升
    • 提高各国的医疗保健意识和支出
  • 市场限制因素
    • 虫媒病毒检测方法的准确性问题
  • 市场机会
    • 消除蚊媒登革热的新测试模型的演变
    • 现代化医疗基础设施的快速投资
  • 市场挑战
    • 虫媒病毒检测的严格核准流程

波特的五力：驾驭虫媒病毒检测市场的策略工具

波特的五力框架是了解虫媒病毒测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解虫媒病毒检测市场的外部影响

外部宏观环境因素在塑造虫媒病毒检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解虫媒病毒检测市场的竞争状况

对虫媒病毒测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵虫媒病毒检测市场供应商绩效评估

FPNV定位矩阵是评估虫媒病毒检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製虫媒病毒检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，虫媒病毒检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 虫媒病毒在人群中的盛行率不断上升
      • 各国医疗保健意识和支出增加
    • 抑制因素
      • 与虫媒病毒检测方法相关的准确性问题
    • 机会
      • 消除蚊媒登革热的新测试模型的演变
      • 现代化医疗基础设施的快速投资
    • 任务
      • 虫媒病毒检测的严格核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章虫媒病毒检测市场：依类型

  • 酵素免疫分析法测定法 (ELISA)
  • RT-PCR检测

第七章虫媒病毒检测市场：依组成部分

  • 设备与设备
  • 实验室耗材
  • 软体和资料管理解决方案

第八章虫媒病毒检测市场（依适应症）

  • 基孔肯雅热
  • 登革热
  • 西尼罗热
  • 黄热病病毒
  • 兹卡热

第九章虫媒病毒测试市场：依最终用户分类

  • 诊断中心
  • 医院
  • 调查机构

第十章美洲虫媒病毒检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区虫媒病毒检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲虫媒病毒检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abnova Corporation
  • Bio-Rad Laboratories, Inc.
  • Biogenix Inc. Pvt. Ltd.
  • Biolab Diagnostics{I}Pvt. Ltd.
  • bioMerieux SA
  • Certest Biotec, SL
  • Creative Diagnostics
  • Diasorin SpA
  • EUROIMMUN Medizinische Labordiagnostika AG
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Hologic, Inc.
  • InBios International, Inc.
  • Intec Products, Inc.
  • Lexicare Pharma Pvt. Ltd.
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Reckon Diagnostics Pvt. Ltd.
  • Response Biomedical Corporation
  • SD Biosensor Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-69324464D0E4

The Arbovirus Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1.85 billion by 2030.

Arbovirus testing refers to the diagnostic procedures employed to detect the presence of arboviruses, which are viruses transmitted to humans and animals via arthropods like mosquitoes and ticks. Given the rising incidence of arboviral infections such as Zika, Dengue, and West Nile Virus, the necessity for arbovirus testing has intensified, primarily to safeguard public health. This testing is crucial in both clinical and vector surveillance contexts and has applications spanning hospitals, diagnostic labs, research institutes, and field surveillance units. Market growth is fueled by heightened awareness of vector-borne diseases, increased government initiatives for outbreak control, and advancements in diagnostic technologies, including PCR and serological methods. The burgeoning demand for rapid, accurate, and point-of-care testing solutions spotlights an emerging opportunity, especially in endemic regions. However, market expansion is hindered by several factors: the high cost of advanced testing devices, logistical challenges in rural or resource-poor settings, and a shortage of skilled personnel to operate sophisticated diagnostic tools. Key areas for innovation include the development of low-cost portable diagnostic kits, enhancing the specificity and sensitivity of testing methods, and integrating artificial intelligence to predict outbreaks. Furthermore, emphasis on research to understand arbovirus mutation patterns and cross-reactivity in serological tests can propel advancements. Firms should consider collaborations with governments and NGOs to facilitate widespread adoption and deploy educational campaigns to amplify the significance of early diagnosis. The arbovirus testing market, while growing, is inherently dynamic and influenced by seasonal trends, regional disease prevalence, and health policy changes. As such, businesses in this domain must maintain agility, prioritize R&D investment, and leverage data analytics to capture emerging trends and tailor products to meet diverse regional needs, thereby securing a robust market position amidst evolving public health landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.31 billion
Forecast Year [2030] USD 1.85 billion
CAGR (%) 5.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arbovirus Testing Market

The Arbovirus Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising rate of prevalence of arboviruses among population
    • Growing healthcare awareness and spending across economies
  • Market Restraints
    • Accuracy issues associated with arbovirus testing methods
  • Market Opportunities
    • Evolution of new testing model to swat mosquito-borne dengue fever
    • Rapid investments in modernized healthcare infrastructures
  • Market Challenges
    • Stringent approval processes for arbovirus testing

Porter's Five Forces: A Strategic Tool for Navigating the Arbovirus Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arbovirus Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arbovirus Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arbovirus Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arbovirus Testing Market

A detailed market share analysis in the Arbovirus Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arbovirus Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arbovirus Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arbovirus Testing Market

A strategic analysis of the Arbovirus Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arbovirus Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Bio-Rad Laboratories, Inc., Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., bioMerieux SA, Certest Biotec, S.L., Creative Diagnostics, Diasorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Hologic, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Response Biomedical Corporation, SD Biosensor Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Arbovirus Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Enzyme-linked Immunosorbent Assays (ELISAs) and RT-PCR Assays.
  • Based on Component, market is studied across Instruments & Equipments, Laboratory Consumables, and Software & Data Management Solutions.
  • Based on Indication, market is studied across Chikungunya, Dengue, West Nile Fever, Yellow Fever Virus, and Zika.
  • Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising rate of prevalence of arboviruses among population
      • 5.1.1.2. Growing healthcare awareness and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Accuracy issues associated with arbovirus testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Evolution of new testing model to swat mosquito-borne dengue fever
      • 5.1.3.2. Rapid investments in modernized healthcare infrastructures
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes for arbovirus testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Arbovirus Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Enzyme-linked Immunosorbent Assays (ELISAs)
  • 6.3. RT-PCR Assays

7. Arbovirus Testing Market, by Component

  • 7.1. Introduction
  • 7.2. Instruments & Equipments
  • 7.3. Laboratory Consumables
  • 7.4. Software & Data Management Solutions

8. Arbovirus Testing Market, by Indication

  • 8.1. Introduction
  • 8.2. Chikungunya
  • 8.3. Dengue
  • 8.4. West Nile Fever
  • 8.5. Yellow Fever Virus
  • 8.6. Zika

9. Arbovirus Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Americas Arbovirus Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Arbovirus Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Arbovirus Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abnova Corporation
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biogenix Inc. Pvt. Ltd.
  • 5. Biolab Diagnostics {I}Pvt. Ltd.
  • 6. bioMerieux SA
  • 7. Certest Biotec, S.L.
  • 8. Creative Diagnostics
  • 9. Diasorin S.p.A.
  • 10. EUROIMMUN Medizinische Labordiagnostika AG
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Getein Biotech, Inc.
  • 13. Hologic, Inc.
  • 14. InBios International, Inc.
  • 15. Intec Products, Inc.
  • 16. Lexicare Pharma Pvt. Ltd.
  • 17. NovaTec Immundiagnostica GmbH
  • 18. OriGene Technologies, Inc.
  • 19. PerkinElmer, Inc.
  • 20. Quest Diagnostics
  • 21. Reckon Diagnostics Pvt. Ltd.
  • 22. Response Biomedical Corporation
  • 23. SD Biosensor Inc.
  • 24. Siemens Healthineers AG
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ARBOVIRUS TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ARBOVIRUS TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARBOVIRUS TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARBOVIRUS TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RT-PCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WEST NILE FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY YELLOW FEVER VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ZIKA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023